Juvenile myelomonocytic leukemia pathophysiology

About 80% of JMML patients have some sort of genetic abnormality in their leukemia cells that can be identified with laboratory testing. This includes:

• 15-20% of patients with neurofibromatosis 1 (NF1)
• 25% of patients with mutations in one of the RAS family of oncogenes (only in their leukemia cells)
• Another 35% of patients with a mutation in a gene called PTPN11 (again, only in their leukemia cells).

fi:Juveniili myelomonosyyttileukemia

Template:WikiDoc Sources